IL6 and postmenopausal osteoporosis: Postmenopausal osteoporosis is a type of systemic bone disease, characterized by a reduction in bone density, degradation of bone microstructure and an alteration in serum markers of bone metabolism, including alkaline phosphatase (ALP), estradiol (E2) and interleukin-6 (IL-6) in postmenopausal females.